1. Home
  2. INDO vs DXR Comparison

INDO vs DXR Comparison

Compare INDO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDO
  • DXR
  • Stock Information
  • Founded
  • INDO 2018
  • DXR 1970
  • Country
  • INDO Indonesia
  • DXR United States
  • Employees
  • INDO N/A
  • DXR N/A
  • Industry
  • INDO Oil & Gas Production
  • DXR Medical/Dental Instruments
  • Sector
  • INDO Energy
  • DXR Health Care
  • Exchange
  • INDO Nasdaq
  • DXR Nasdaq
  • Market Cap
  • INDO 40.1M
  • DXR 42.6M
  • IPO Year
  • INDO 2019
  • DXR N/A
  • Fundamental
  • Price
  • INDO $2.78
  • DXR $8.31
  • Analyst Decision
  • INDO
  • DXR Strong Buy
  • Analyst Count
  • INDO 0
  • DXR 1
  • Target Price
  • INDO N/A
  • DXR $24.75
  • AVG Volume (30 Days)
  • INDO 445.6K
  • DXR 38.6K
  • Earning Date
  • INDO 12-27-2024
  • DXR 01-01-0001
  • Dividend Yield
  • INDO N/A
  • DXR N/A
  • EPS Growth
  • INDO N/A
  • DXR N/A
  • EPS
  • INDO N/A
  • DXR 0.35
  • Revenue
  • INDO $3,127,587.00
  • DXR $154,205.00
  • Revenue This Year
  • INDO N/A
  • DXR N/A
  • Revenue Next Year
  • INDO N/A
  • DXR N/A
  • P/E Ratio
  • INDO N/A
  • DXR $24.10
  • Revenue Growth
  • INDO N/A
  • DXR N/A
  • 52 Week Low
  • INDO $2.03
  • DXR $7.19
  • 52 Week High
  • INDO $6.65
  • DXR $10.04
  • Technical
  • Relative Strength Index (RSI)
  • INDO 37.95
  • DXR 36.99
  • Support Level
  • INDO $2.62
  • DXR $8.11
  • Resistance Level
  • INDO $3.09
  • DXR $8.42
  • Average True Range (ATR)
  • INDO 0.16
  • DXR 0.36
  • MACD
  • INDO 0.01
  • DXR -0.13
  • Stochastic Oscillator
  • INDO 12.50
  • DXR 0.53

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: